Quarterly report pursuant to Section 13 or 15(d)

Derivative Liabilities (Details) - Schedule of Measured at Fair Value on a Recurring Basis

v3.24.3
Derivative Liabilities (Details) - Schedule of Measured at Fair Value on a Recurring Basis - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Schedule of Measured at Fair Value on a Recurring Basis [Line Items]            
Beginning balance $ 249 $ 58   $ 58  
Change in fair value of derivative liabilities (249) 191 $ (2,036) (58) $ (69,776)
Ending balance 249    
Public SPAC Warrants [Member]            
Schedule of Measured at Fair Value on a Recurring Basis [Line Items]            
Beginning balance [1] 249 58   58  
Change in fair value of derivative liabilities [1] (249) 191      
Ending balance [1] 249    
Private SPAC Warrants [Member]            
Schedule of Measured at Fair Value on a Recurring Basis [Line Items]            
Beginning balance [1]    
Change in fair value of derivative liabilities [1]      
Ending balance [1]    
PIPE Warrants [Member]            
Schedule of Measured at Fair Value on a Recurring Basis [Line Items]            
Beginning balance [1]    
Change in fair value of derivative liabilities [1]      
Ending balance [1]    
Other Warrants [Member]            
Schedule of Measured at Fair Value on a Recurring Basis [Line Items]            
Beginning balance [1]    
Change in fair value of derivative liabilities [1]      
Ending balance [1]    
[1] There are 15,132 shares underlying the Public SPAC warrants, 662 shares underlying the Private SPAC warrants, 6,748 shares underlying the PIPE warrants and 168 shares underlying the Other warrants outstanding as of September 30, 2024.